These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

112 related articles for article (PubMed ID: 32643303)

  • 61. Modeling parkinsonian circuitry and the DBS electrode. II. Evaluation of a computer simulation model of the basal ganglia with and without subthalamic nucleus stimulation.
    Shils JL; Mei LZ; Arle JE
    Stereotact Funct Neurosurg; 2008; 86(1):16-29. PubMed ID: 17881885
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Acute psychotropic effects of bilateral subthalamic nucleus stimulation and levodopa in Parkinson's disease.
    Funkiewiez A; Ardouin C; Krack P; Fraix V; Van Blercom N; Xie J; Moro E; Benabid AL; Pollak P
    Mov Disord; 2003 May; 18(5):524-30. PubMed ID: 12722166
    [TBL] [Abstract][Full Text] [Related]  

  • 63. A network analysis of ¹⁵O-H₂O PET reveals deep brain stimulation effects on brain network of Parkinson's disease.
    Park HJ; Park B; Kim HY; Oh MK; Kim JI; Yoon M; Lee JD; Chang JW
    Yonsei Med J; 2015 May; 56(3):726-36. PubMed ID: 25837179
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Basal ganglia, movement disorders and deep brain stimulation: advances made through non-human primate research.
    Wichmann T; Bergman H; DeLong MR
    J Neural Transm (Vienna); 2018 Mar; 125(3):419-430. PubMed ID: 28601961
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Subthalamic stimulation may inhibit the beneficial effects of levodopa on akinesia and gait.
    Fleury V; Pollak P; Gere J; Tommasi G; Romito L; Combescure C; Bardinet E; Chabardes S; Momjian S; Krainik A; Burkhard P; Yelnik J; Krack P
    Mov Disord; 2016 Sep; 31(9):1389-97. PubMed ID: 26887333
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Deep brain stimulation improves survival in severe Parkinson's disease.
    Ngoga D; Mitchell R; Kausar J; Hodson J; Harries A; Pall H
    J Neurol Neurosurg Psychiatry; 2014 Jan; 85(1):17-22. PubMed ID: 23843542
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Effects of deep brain stimulation of the subthalamic nucleus on freezing of gait in Parkinson's disease: a prospective controlled study.
    Vercruysse S; Vandenberghe W; Münks L; Nuttin B; Devos H; Nieuwboer A
    J Neurol Neurosurg Psychiatry; 2014 Aug; 85(8):871-7. PubMed ID: 24396010
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Simultaneous repetitive movements following pallidotomy or subthalamic deep brain stimulation in patients with Parkinson's disease.
    Levy R; Lang AE; Hutchison WD; Lozano AM; Dostrovsky JO
    Exp Brain Res; 2002 Dec; 147(3):322-31. PubMed ID: 12428140
    [TBL] [Abstract][Full Text] [Related]  

  • 69. [Deep brain stimulation in the management of Parkinson's disease].
    Zabek M; Sobstyl M
    Neurol Neurochir Pol; 2006; 40(3):203-11. PubMed ID: 16794960
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Successful Management of Hemorrhage-Associated Hemiballism After Subthalamic Nucleus Deep Brain Stimulation with Pallidal Stimulation: a Case Report.
    Pabaney A; Ali R; Lewitt PA; Sidiropoulos C; Schwalb JM
    World Neurosurg; 2015 Oct; 84(4):1176.e1-3. PubMed ID: 26164193
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Subthalamic Nucleus Deep Brain Stimulation Modulate Catecholamine Levels with Significant Relations to Clinical Outcome after Surgery in Patients with Parkinson's Disease.
    Yamamoto T; Uchiyama T; Higuchi Y; Asahina M; Hirano S; Yamanaka Y; Kuwabara S
    PLoS One; 2015; 10(9):e0138462. PubMed ID: 26394059
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Stimulation sites in the subthalamic nucleus and clinical improvement in Parkinson's disease: a new approach for active contact localization.
    Garcia-Garcia D; Guridi J; Toledo JB; Alegre M; Obeso JA; Rodríguez-Oroz MC
    J Neurosurg; 2016 Nov; 125(5):1068-1079. PubMed ID: 26848922
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Eye movements in Parkinson's disease: from neurophysiological mechanisms to diagnostic tools.
    Antoniades CA; Spering M
    Trends Neurosci; 2024 Jan; 47(1):71-83. PubMed ID: 38042680
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Deep Brain Stimulation Programming 2.0: Future Perspectives for Target Identification and Adaptive Closed Loop Stimulation.
    Hell F; Palleis C; Mehrkens JH; Koeglsperger T; Bötzel K
    Front Neurol; 2019; 10():314. PubMed ID: 31001196
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Deep-Brain Stimulation for Basal Ganglia Disorders.
    Wichmann T; Delong MR
    Basal Ganglia; 2011 Jul; 1(2):65-77. PubMed ID: 21804953
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Deep brain stimulation-induced neuroprotection: A critical appraisal.
    Ashkan K; Velicu MA; Furlanetti L
    Eur J Paediatr Neurol; 2022 Mar; 37():114-122. PubMed ID: 35189499
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Targeting circuits with DBS.
    Yates D
    Nat Rev Neurosci; 2021 Dec; 22(12):721. PubMed ID: 34716447
    [No Abstract]   [Full Text] [Related]  

  • 78. Editorial: Towards the Next Generation of Deep Brain Stimulation Therapies: Technological Advancements, Computational Methods, and New Targets.
    Santaniello S; McConnell GC; Gale JT; Faghih RT; Kemere C; Hilliard JD; Han M
    Front Neurosci; 2021; 15():737737. PubMed ID: 34489638
    [No Abstract]   [Full Text] [Related]  

  • 79. The epistemology of Deep Brain Stimulation and neuronal pathophysiology.
    Montgomery EB
    Front Integr Neurosci; 2012; 6():78. PubMed ID: 23024631
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Acute head- and gaze deviation, facial asymmetry and anarthria mimicking stroke, caused by short circuit in deep brain stimulation.
    Schröter N; Hager A; Rau A; Urbach H; Coenen VA; Rijntjes M
    Brain Stimul; 2022; 15(1):257-259. PubMed ID: 34999007
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.